newsfilter
← Latest News
GlobeNewswire·

Ultragenyx to Participate at Bank of America's 2026 Healthcare Conference

  • Ultragenyx Pharmaceutical Inc. announced that CFO Howard Horn & VP of Investor Relations Joshua Higa will participate in a fireside chat at the Bank of America 2026 Healthcare Conference.
  • The event is scheduled for Tuesday, May 12, 2026, at 2:20 PM PT.
  • A live & archived webcast of the session will be available on the company's investor relations website at https://ir.ultragenyx.com/events-presentations.
  • Ultragenyx is a biopharmaceutical company focused on developing & commercializing therapies for serious rare & ultra-rare genetic diseases.
  • The company's strategy emphasizes time- & cost-efficient drug development to deliver safe & effective treatments urgently.